Collegium Pharmaceutical, Inc.
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| FY2021 | $103.6M | $101.6M | $1.9M | $24.3M |
| FY2022 | $124.2M | $122.6M | $1.6M | $22.9M |
| FY2023 | $274.7M | $274.3M | $461.0K | $27.1M |
| FY2024 | $205.0M | $203.3M | $1.7M | $32.4M |
| FY2025 | $329.3M | $327.6M | $1.7M | $41.9M |